KIG
BIIB icon

Kennedy Investment Group’s Biogen BIIB Stock Holding History

Kennedy Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,615
Closed -$203K – 139
2025
Q2 		$203K Sell
1,615
-58
-3% -$7.23K 0.09% 132
2025
Q1 		$229K Sell
1,673
-248
-13% -$35.5K 0.11% 116
2024
Q4 		$294K Sell
1,921
-172
-8% -$29K 0.13% 103
2024
Q3 		$406K Sell
2,093
-69
-3% -$14.4K 0.19% 96
2024
Q2 		$501K Sell
2,162
-22
-1% -$4.78K 0.25% 81
2024
Q1 		$471K Buy
2,184
+3
+0.1% +$703 0.25% 83
2023
Q4 		$564K Hold
2,181
– – 0.32% 76
2023
Q3 		$561K Sell
2,181
-35
-2% -$9.36K 0.34% 74
2023
Q2 		$631K Sell
2,216
-88
-4% -$26.2K 0.37% 70
2023
Q1 		$641K Sell
2,304
-53
-2% -$14.7K 0.39% 65
2022
Q4 		$653K Buy
+2,357
New +$666K 0.42% 65

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Kennedy Investment Group's BIIB Position: Q3 2025 in Review

Kennedy Investment Group sold out of Biogen (BIIB) in Q3 2025, closing a stake of 1,615 shares — an estimated $203K sold.

Kennedy Investment Group first reported a position in BIIB in Q4 2022 and held it in 11 quarters. The position peaked at $653K in Q4 2022. 907 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Kennedy Investment Group reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Kennedy Investment Group sold 1,615 Biogen shares in Q3 2025, an estimated $203K.
  • Kennedy Investment Group first reported a position in Biogen in Q4 2022 and held it in 11 quarters.
  • Kennedy Investment Group's Biogen position peaked at $653K in Q4 2022.
  • 907 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Kennedy Investment Group's 13F filing for Q3 2025, filed 28 Oct 2025.